** Shares of healthcare product distributor Henry Schein HSIC.O fall 1.7% to $76.31
** Co forecasts 2025 profit between $4.80 and $4.94 per share, lower than analysts' estimates of $4.99, per data compiled by LSEG
** HSIC reports Q4 profit of $1.19/share vs est of $1.21/share
** Total Q4 sales of $3.2 bln misses est of $3.29 bln
** HSIC expects revenue to grow by 2% to 4% from the $12.67 bln reported in 2024
** Stock has fallen 2.7% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。